NO328103B1 - Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav - Google Patents

Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav Download PDF

Info

Publication number
NO328103B1
NO328103B1 NO20020163A NO20020163A NO328103B1 NO 328103 B1 NO328103 B1 NO 328103B1 NO 20020163 A NO20020163 A NO 20020163A NO 20020163 A NO20020163 A NO 20020163A NO 328103 B1 NO328103 B1 NO 328103B1
Authority
NO
Norway
Prior art keywords
methyl
fluorophenyl
reaction
formula
mmol
Prior art date
Application number
NO20020163A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020163D0 (no
NO20020163L (no
Inventor
Ulrich Veith
Original Assignee
Lonza Ag Lonza Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag Lonza Ltd filed Critical Lonza Ag Lonza Ltd
Publication of NO20020163D0 publication Critical patent/NO20020163D0/no
Publication of NO20020163L publication Critical patent/NO20020163L/no
Publication of NO328103B1 publication Critical patent/NO328103B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020163A 1999-07-13 2002-01-11 Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav NO328103B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP99113711 1999-07-13
EP99120417 1999-10-14
US18537100P 2000-02-28 2000-02-28
US18546500P 2000-02-28 2000-02-28
EP00106303 2000-03-23
PCT/EP2000/006099 WO2001004100A1 (en) 1999-07-13 2000-06-30 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate

Publications (3)

Publication Number Publication Date
NO20020163D0 NO20020163D0 (no) 2002-01-11
NO20020163L NO20020163L (no) 2002-01-11
NO328103B1 true NO328103B1 (no) 2009-12-07

Family

ID=27513029

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020163A NO328103B1 (no) 1999-07-13 2002-01-11 Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav
NO20092393A NO334937B1 (no) 1999-07-13 2009-06-23 Fremgangsmåte for fremstilling av N-cyano-N-alkylalkansulfonamider og 4-fenylpyrimidiner samt slike forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20092393A NO334937B1 (no) 1999-07-13 2009-06-23 Fremgangsmåte for fremstilling av N-cyano-N-alkylalkansulfonamider og 4-fenylpyrimidiner samt slike forbindelser

Country Status (17)

Country Link
US (3) US6579984B1 (cs)
EP (1) EP1194414B1 (cs)
JP (1) JP4649813B2 (cs)
KR (1) KR100649927B1 (cs)
CN (1) CN1164577C (cs)
AT (1) ATE307120T1 (cs)
AU (1) AU6266600A (cs)
CA (1) CA2378782C (cs)
CZ (1) CZ304307B6 (cs)
DE (1) DE60023296T2 (cs)
ES (1) ES2251392T3 (cs)
HK (1) HK1046682B (cs)
HU (1) HU228303B1 (cs)
NO (2) NO328103B1 (cs)
PL (1) PL211797B1 (cs)
SK (1) SK285993B6 (cs)
WO (1) WO2001004100A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AR034772A1 (es) * 2001-07-13 2004-03-17 Astrazeneca Uk Ltd Preparacion de los compuestos de aminopirimidina
RU2301801C2 (ru) * 2001-07-13 2007-06-27 АстраЗенека Ю-Кей Лимитед Способ получения сульфониламинопиримидиновых соединений (варианты), промежуточные продукты и способы их получения
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
ATE448209T1 (de) 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
ES2879314T3 (es) 2010-08-18 2021-11-22 Biosplice Therapeutics Inc Dicetonas e hidroxicetonas como activadores de la vía de señalización de catenina
PL2968249T3 (pl) 2013-02-22 2019-06-28 Samumed, Llc Gamma-diketony jako aktywatory szlaku sygnałowego Wnt/beta-kateniny
CN103910644B (zh) * 2014-04-21 2015-06-24 广西师范大学 β-烯胺酮酯类化合物及其合成方法和应用
US9795550B2 (en) 2014-08-20 2017-10-24 Samumed, Llc Gamma-diketones for treatment and prevention of aging skin and wrinkles
CN110483341A (zh) * 2019-07-23 2019-11-22 上海药明康德新药开发有限公司 一种1-氰基-n-甲基甲磺酰胺的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013706A (en) * 1973-11-14 1977-03-22 Sucreries Du Soissonnais Et Compagnie Sucriere Derivatives of substituted urea, acyl ureas, and sulphonyl ureas, and a process for producing the same
DE3717815A1 (de) * 1987-05-27 1988-12-15 Bayer Ag Fungizide mittel auf basis von substituierten cyanamiden
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3197971B2 (ja) * 1993-03-01 2001-08-13 塩野義製薬株式会社 5−カルボアルコキシピリミジン誘導体の合成方法

Also Published As

Publication number Publication date
CA2378782C (en) 2009-11-10
NO20092393L (no) 2002-01-11
EP1194414A1 (en) 2002-04-10
HUP0202006A2 (hu) 2002-12-28
DE60023296D1 (de) 2006-03-02
HK1046682B (zh) 2005-04-08
ATE307120T1 (de) 2005-11-15
NO334937B1 (no) 2014-07-21
CZ304307B6 (cs) 2014-02-26
CN1164577C (zh) 2004-09-01
KR100649927B1 (ko) 2006-11-27
SK222002A3 (en) 2002-06-04
WO2001004100A1 (en) 2001-01-18
ES2251392T3 (es) 2006-05-01
US6984757B2 (en) 2006-01-10
JP2003504359A (ja) 2003-02-04
AU6266600A (en) 2001-01-30
US6710178B2 (en) 2004-03-23
CA2378782A1 (en) 2001-01-18
NO20020163D0 (no) 2002-01-11
US20040181065A1 (en) 2004-09-16
PL353058A1 (en) 2003-10-06
CZ200261A3 (cs) 2002-05-15
CN1370151A (zh) 2002-09-18
NO20020163L (no) 2002-01-11
JP4649813B2 (ja) 2011-03-16
SK285993B6 (sk) 2008-01-07
HK1046682A1 (en) 2003-01-24
HUP0202006A3 (en) 2003-02-28
DE60023296T2 (de) 2006-07-20
PL211797B1 (pl) 2012-06-29
EP1194414B1 (en) 2005-10-19
KR20020012007A (ko) 2002-02-09
US20030199695A1 (en) 2003-10-23
HU228303B1 (hu) 2013-03-28
US6579984B1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
NO334937B1 (no) Fremgangsmåte for fremstilling av N-cyano-N-alkylalkansulfonamider og 4-fenylpyrimidiner samt slike forbindelser
JP2023027091A (ja) アミノピリミジン誘導体を調製するための改善されたプロセス
CA2646795A1 (en) Process for the preparation of bosentan
KR20170029656A (ko) 피리미딘 술파미드 유도체의 제조 방법
EP2350025A1 (en) An improved process for preparing pyrimidine propenaldehyde
EP0483204B1 (en) Process for preparing 2,5-diamino-4,6-dichloropyrimidine
KR100535450B1 (ko) 피리미딘유도체의제조방법
WO2008059519A2 (en) A process for the preparation of intermediates of rosuvastatin
US6187926B1 (en) Process for producing quinolone derivatives
US5266697A (en) Process for the production of 2-substituted 4,6-dialkoxypyrimidines
AU658965B2 (en) N-5-protected 2,5-diamino-4,6-dichloro-pyrimidines and processes for their preparation
JP6375374B2 (ja) ピリミジン中間体の製造方法
WO2011021216A2 (en) Improved process for the preparation of 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide
JPH11147879A (ja) 非対称4,6−ビス(アリールオキシ)ピリミジン化合物の改良された製造方法
WO2017093903A1 (en) An improved process for the preparation of macitentan
EP0515464B1 (en) Process for preparing uracil derivatives
WO2011121598A1 (en) Crystalline 7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3(r)-hydroxy-5-oxo-hept-6-enoic acid methyl ester and process thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees